00:00
08:40
Lead administrator and physician from Bellin Health share their journey of navigating the corridor from volume to value-based healthcare and address these important questions:
•What does volume-to-value mean for you?
•How are physicians reacting to this new population health model?
•Why have you decided to focus on understanding cost of care?
•From a population health perspective, what focus areas are you targeting for 2019?

Andrea Werner, MSW is Senior Vice President for Cardiovascular and Pulmonology; Neurosciences, Orthopedics, and Sports Medicine; and Pathology and Radiology for Bellin Health in Green Bay, Wisconsin. James Rider, MD is the Director of Cardiovascular Research, Nuclear Cardiology, and the CHF program for Bellin Health in Green Bay, Wisconsin. Lori Walsh, MHSA is Vice President - Membership and Senior Consultant for MedAxiom.
Lead administrator and physician from Bellin Health share their journey of navigating the corridor from volume to value-based healthcare and address these important questions: •What does volume-to-value mean for you? •How are physicians reacting to this new population health model? •Why have you decided to focus on understanding cost of care? •From a population health perspective, what focus areas are you targeting for 2019? Andrea Werner, MSW is Senior Vice President for Cardiovascular and Pulmonology; Neurosciences, Orthopedics, and Sports Medicine; and Pathology and Radiology for Bellin Health in Green Bay, Wisconsin. James Rider, MD is the Director of Cardiovascular Research, Nuclear Cardiology, and the CHF program for Bellin Health in Green Bay, Wisconsin. Lori Walsh, MHSA is Vice President - Membership and Senior Consultant for MedAxiom. read more read less

4 years ago #a-fib, #afib, #atrial, #care, #chf, #congestive, #cost, #failure, #fee-for-service, #fibrillation, #healthcare, #heart, #value, #volume, #volume-to-value